These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21949409)

  • 21. Nanoparticles: A personal experience for formulating poorly water soluble drugs.
    Cooper ER
    J Control Release; 2010 Feb; 141(3):300-2. PubMed ID: 19822177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicology of gallates: a review and evaluation.
    van der Heijden CA; Janssen PJ; Strik JJ
    Food Chem Toxicol; 1986; 24(10-11):1067-70. PubMed ID: 3542759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The apparent solubilizing capacity of simulated intestinal fluids for poorly water-soluble drugs.
    Schwebel HJ; van Hoogevest P; Leigh ML; Kuentz M
    Pharm Dev Technol; 2011 Jun; 16(3):278-86. PubMed ID: 20214530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ultraviolet spectral characteristics of charge-transfer reaction complex in micellar system and its application].
    Du LM; Chen CP; Li JH
    Guang Pu Xue Yu Guang Pu Fen Xi; 2005 Feb; 25(2):277-9. PubMed ID: 15852876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of aqueous solubility from SCRATCH.
    Jain P; Yalkowsky SH
    Int J Pharm; 2010 Jan; 385(1-2):1-5. PubMed ID: 19819319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial activity of akyl gallates against Bacillus subtilis.
    Kubo I; Fujita K; Nihei K; Nihei A
    J Agric Food Chem; 2004 Mar; 52(5):1072-6. PubMed ID: 14995100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of pH-dependent aqueous solubility of druglike molecules.
    Hansen NT; Kouskoumvekaki I; Jørgensen FS; Brunak S; Jónsdóttir SO
    J Chem Inf Model; 2006; 46(6):2601-9. PubMed ID: 17125200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The utility of cyclodextrins for enhancing oral bioavailability.
    Carrier RL; Miller LA; Ahmed I
    J Control Release; 2007 Nov; 123(2):78-99. PubMed ID: 17888540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guiding molecules towards drug-likeness.
    Egan WJ; Walters WP; Murcko MA
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):540-9. PubMed ID: 12197312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of L-arginine on solubilization and purification of plant membrane proteins.
    Arakawa J; Uegaki M; Ishimizu T
    Protein Expr Purif; 2011 Nov; 80(1):91-6. PubMed ID: 21640827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Amorphization in pharmaceutical technology].
    Révész P; Laczkovich O; Eros I
    Acta Pharm Hung; 2004; 74(1):39-44. PubMed ID: 15524047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrochemical Insights on the Hydrophobicity of Cellulose Substrates Imparted by Enzymatically Oxidized Gallates with Increasing Alkyl Chain Length.
    Cusola O; Valls C; Vidal T; Tzanov T; Roncero MB
    ACS Appl Mater Interfaces; 2015 Jul; 7(25):13834-41. PubMed ID: 26057550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Micellar solubilization of drugs.
    Rangel-Yagui CO; Pessoa A; Tavares LC
    J Pharm Pharm Sci; 2005 Jul; 8(2):147-65. PubMed ID: 16124926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An automated system for determining drug solubility based on laser monitoring technique.
    Jouyban-Gharamaleki V; Jouyban-Gharamaleki K; Shayanfar A; Khoubnasabjafari M; Jouyban A
    J Lab Autom; 2015 Feb; 20(1):3-9. PubMed ID: 25331492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structures of drugs: advances in determination, prediction and engineering.
    Datta S; Grant DJ
    Nat Rev Drug Discov; 2004 Jan; 3(1):42-57. PubMed ID: 14708020
    [No Abstract]   [Full Text] [Related]  

  • 37. Turbidimetric measurement and prediction of dissolution rates of poorly soluble drug nanocrystals.
    Crisp MT; Tucker CJ; Rogers TL; Williams RO; Johnston KP
    J Control Release; 2007 Feb; 117(3):351-9. PubMed ID: 17239469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An in vitro kinetic method for detection of precipitation of poorly soluble drugs.
    Wu Z; Tucker IG; Razzak M; Medlicott NJ
    Int J Pharm; 2005 Nov; 304(1-2):1-3. PubMed ID: 16198520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asymmetric membrane capsule for osmotic delivery of flurbiprofen.
    Choudhury PK; Ranawat MS; Pillai MK; Chauhan CS
    Acta Pharm; 2007 Sep; 57(3):343-50. PubMed ID: 17878113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.
    Müllertz A; Ogbonna A; Ren S; Rades T
    J Pharm Pharmacol; 2010 Nov; 62(11):1622-36. PubMed ID: 21039546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.